Abraham
Group Head of Oncology Research and Development
Oncology
Pfizer
Austria
Biography
Robert Abraham (Bob) is Senior Vice President and Group Head, Oncology Research & Development Group. This group is at the forefront of breaking new ground to develop impactful, life-saving cancer therapies and spearheading the company’s Precision Medicine approach to Research and Development. Dr. Abraham also serves as the Director of the Pfizer Postdoctoral program, helping develop talented early career scientists into outstanding industry and academic researchers. Dr. Abraham received his PhD in pharmacology at the University of Pittsburgh, and his BS in Biology from Bucknell University. He is the author of more than 200 scientific publications, and has served on and chaired grant review panels at the National Institutes of Health. He is a reviewer for many leading scientific journals, including Nature, Science, and Cell.
Research Interest
Molecular Cancer Biology, Immunology and Pharmacology.
